Zynex Basic Shares Outstanding 2010-2025 | ZYXI
Zynex basic shares outstanding from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
| Zynex Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $32 |
| 2023 | $36 |
| 2022 | $38 |
| 2021 | $38 |
| 2020 | $37 |
| 2019 | $36 |
| 2018 | $36 |
| 2017 | $35 |
| 2016 | $34 |
| 2015 | $34 |
| 2014 | $34 |
| 2013 | $34 |
| 2012 | $34 |
| 2011 | $34 |
| 2010 | $34 |
| 2009 | $33 |
| Zynex Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $32 |
| 2024-12-31 | $32 |
| 2024-09-30 | $32 |
| 2024-06-30 | $32 |
| 2024-03-31 | $32 |
| 2023-12-31 | $36 |
| 2023-09-30 | $36 |
| 2023-06-30 | $36 |
| 2023-03-31 | $37 |
| 2022-12-31 | $38 |
| 2022-09-30 | $38 |
| 2022-06-30 | $39 |
| 2022-03-31 | $40 |
| 2021-12-31 | $38 |
| 2021-09-30 | $38 |
| 2021-06-30 | $38 |
| 2021-03-31 | $38 |
| 2020-12-31 | $37 |
| 2020-09-30 | $38 |
| 2020-06-30 | $37 |
| 2020-03-31 | $36 |
| 2019-12-31 | $36 |
| 2019-09-30 | $36 |
| 2019-06-30 | $36 |
| 2019-03-31 | $35 |
| 2018-12-31 | $36 |
| 2018-09-30 | $36 |
| 2018-06-30 | $36 |
| 2018-03-31 | $36 |
| 2017-12-31 | $35 |
| 2017-09-30 | $36 |
| 2017-06-30 | $35 |
| 2017-03-31 | $35 |
| 2016-12-31 | $34 |
| 2016-09-30 | $34 |
| 2016-06-30 | $34 |
| 2016-03-31 | $34 |
| 2015-12-31 | $34 |
| 2015-09-30 | $34 |
| 2015-06-30 | $34 |
| 2015-03-31 | $34 |
| 2014-12-31 | $34 |
| 2014-09-30 | $34 |
| 2014-06-30 | $34 |
| 2014-03-31 | $34 |
| 2013-12-31 | $34 |
| 2013-09-30 | $34 |
| 2013-06-30 | $34 |
| 2013-03-31 | $34 |
| 2012-12-31 | $34 |
| 2012-09-30 | $34 |
| 2012-06-30 | $34 |
| 2012-03-31 | $34 |
| 2011-12-31 | $34 |
| 2011-09-30 | $34 |
| 2011-06-30 | $34 |
| 2011-03-31 | $34 |
| 2010-12-31 | $34 |
| 2010-09-30 | $34 |
| 2010-06-30 | $34 |
| 2010-03-31 | $34 |
| 2009-12-31 | $33 |
| 2009-09-30 | $33 |
| 2009-06-30 | $33 |
| 2009-03-31 | $33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.070B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.085B | 27.79 |
| Boston Scientific (BSX) | United States | $155.238B | 38.86 |
| Stryker (SYK) | United States | $144.362B | 30.18 |
| EssilorLuxottica (ESLOY) | France | $132.860B | 0.00 |
| Medtronic (MDT) | Ireland | $108.824B | 15.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.259B | 27.44 |
| ResMed (RMD) | United States | $35.183B | 26.43 |
| GE HealthCare Technologies (GEHC) | United States | $32.295B | 15.33 |
| Agilent Technologies (A) | United States | $30.971B | 20.46 |
| Terumo (TRUMY) | Japan | $29.019B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.053B | 17.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.255B | 12.80 |
| Insulet (PODD) | United States | $18.084B | 77.18 |
| Baxter (BAX) | United States | $15.752B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.535B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.447B | 18.31 |
| Bio-Rad Laboratories (BIO) | United States | $6.620B | 22.38 |
| Prestige Consumer Healthcare (PBH) | United States | $4.171B | 19.90 |
| Perrigo (PRGO) | Ireland | $3.497B | 10.01 |
| ICU Medical (ICUI) | United States | $3.486B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.208B | 15.10 |
| Envista Holdings (NVST) | United States | $2.880B | 23.93 |
| GN Store Nord (GNNDY) | Denmark | $2.068B | 17.13 |
| QuidelOrtho (QDEL) | United States | $1.964B | 16.45 |
| LeMaitre Vascular (LMAT) | United States | $1.778B | 39.75 |
| AtriCure (ATRC) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 21.63 |
| Neogen (NEOG) | United States | $1.248B | 15.97 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.200B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.184B | 11.40 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.789B | 12.10 |
| Evolus (EOLS) | United States | $0.779B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.637B | 0.00 |
| CeriBell (CBLL) | United States | $0.588B | 0.00 |
| Owens & Minor (OMI) | United States | $0.580B | 4.94 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.458B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.418B | 0.00 |
| Surmodics (SRDX) | United States | $0.395B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 15.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.296B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.291B | 26.32 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 48.40 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.60 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.233B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.231B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Biote (BTMD) | United States | $0.190B | 4.35 |
| Utah Medical Products (UTMD) | United States | $0.173B | 13.93 |
| Brainsway (BWAY) | Israel | $0.170B | 53.06 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Organigram Global (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.22 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.108B | 0.00 |
| Agape ATP (ATPC) | $0.099B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 61.50 |
| United-Guardian (UG) | United States | $0.037B | 11.28 |
| Safety Shot (SHOT) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |